Topics

Glioblastoma | Outcomes | Survival

Home > Publications > Topics > Glioblastoma > Outcomes > Survival

Gonçalves JM, Ferreira F, Carvalho B, Polónia P, Linhares P.
Survival Determinants in Glioblastoma: An Insight into Biopsy-Only Patient Outcomes.
Biomedicines. 2024 Oct 13;12(10):2327. doi: 10.3390/biomedicines12102327. PMID: 39457639. Observational study. ˍ

Alirezaei Z, Amouheidari A, BasirianJahromi R, Seyyedhosseini S, Hamidi A.
Survival Analysis of Glioblastoma: A Scientometric Perspective.
World Neurosurg. 2024 Nov 20:S1878-8750(24)01919-3? doi: 10.1016/j.wneu.2024.11.059? PMID: 39577630. Bibliometric analysis˰ ˍ

Pohan RA, Khadijah K, Pohan PBA, Aditya RS, Ramadhani E, Saputra R, Astuti RD.
Survival in elderly glioblastoma patients: The often overlooked role of radiotherapy and chemotherapy.
J Clin Neurosci. 2025 Jan 29:111091. doi: 10.1016/j.jocn.2025.111091. PMID: 39880728. Observational study˰ ˍ

Shah S, Nag A, Lucke-Wold B.
Association of tumor treating fields (TTFields) therapy with overall survival in newly diagnosed glioblastoma.
Clin Transl Oncol. 2025 Feb 1. doi: 10.1007/s12094-025-03849-6. PMID: 39893330. Review˰ ˍ

Pham J, Cote DJ, Kang K, Briggs RG, Gomez D, Prasad A, Daggupati S, Sisti J, Chow F, Attenello F, Chen CC, Zada G.
Treatment practices and survival outcomes for IDH-wildtype glioblastoma patients according to MGMT promoter methylation status: insights from the U.S. National Cancer Database.
J Neurooncol. 2025 Feb 5. doi: 10.1007/s11060-025-04952-y. PMID: 39907975. Observational study. ˍ

*van Dijck JTJM, Ardon H, Balvers RK, Bos EM, Bosscher L, Brouwers HB, Ho VKY, Hovinga K, Kwee L, Ter Laan M, Nabuurs RJA, Robe PAJT, van Geest S, van der Veer O, Verburg N, Wagemakers M, de Witt Hamer PC, Rodriguez Girondo M, Nandoe Tewarie RDS; Quality Registry Neuro Surgery glioblastoma working group from the Dutch Society of Neurosurgery.
Survival prediction in glioblastoma: 10-year follow-up from the Dutch Neurosurgery Quality Registry.
J Neurooncol. 2025 May 23. doi: 10.1007/s11060-025-05080-3. PMID: 40410639. Observational study. ˍ

Scheu K, Vandieken E, Hense K, Rosengarth K, Haedenkamp T, Lenglinger M, Bumes E, Linker R, Proescholdt M, Schmidt NO, Riemenschneider MJ, Wendl C, Wiesinger I, Hau P.
MRI-defined patterns of infiltration and outcome in patients with glioblastoma.
Neurooncol Adv. 2025 Jul 10;7(1):vdaf114. doi: 10.1093/noajnl/vdaf114. PMID: 40842643. Observational study. ˍ AI Overv

*Bonucci M, Fuggetta MP, Anelli L, Giannarelli D, Fiorentini C, Ravagnan G.
New Approach for Enhancing Survival in Glioblastoma Patients: A Longitudinal Pilot Study on Integrative Oncology.
Cancers (Basel). 2025 Jul 12;17(14):2321. doi: 10.3390/cancers17142321. PMID: 40723205. Observational study. ˍ

Prosperetti C, Yenigün M, Pagnamenta A, Tabaee Damavandi P, Disanto G, Marchi F, Espeli V, Muoio B, Spina P, Pesce G, Agazzi P.
Sex-Related Differences in Glioblastoma: A Single-Center Retrospective Cohort Study.
Biomedicines. 2025 Jul 14;13(7):1715. doi: 10.3390/biomedicines13071715. PMID: 40722784. Observational study. ˍ

Haisraely O, Vedala S, Al-Sharfeen A, Manzar GS, Perni S, Tom MC, Beckham TH, Wang C, Yeboa DN, Chung C, McAleer MF, Ghia AJ, Ene CI, Weathers SP, McGovern SL, Wogan CF, Roth M, Li J, De B.
Glioblastoma in young adult patients: contemporary patterns of care and survival in the United States.
J Neurooncol. 2025 Jul 15. doi: 10.1007/s11060-025-05135-5. PMID: 40663309. Observational study˰ ˍ

Oki S, Yamaguchi S, Ishi Y, Motegi H, Gekka M, Tanei ZI, Kanno-Okada H, Takakuwa E, Tanaka S, Mori T, Nishioka K, Aoyama H, Tanaka S, Fujimura M.
Recurrence patterns and clinical outcomes in adult cerebellar glioblastoma.
Acta Neurochir (Wien). 2025 Aug 8;167(1):217. doi: 10.1007/s00701-025-06633-1. PMID: 40779131. Observational study. ˍ AI Overv

Ferles A, Majewska P, Holden Helland R, Kommers I, Pedersen A, Tranfa M, Ardon H, Bello L, Berger MS, Dunås T, Nibali MC, Furtner J, Hervey-Jumper SL, Idema AJS, Kiesel B, Tewarie RN, Mandonnet E, Robe PA, Rossi M, Sciortino T, Aalders T, Wagemakers M, Widhalm G, Zwinderman AH, Sagberg LM, Jakola AS, Thurin E, Reinertsen I, Bouget D, Solheim O, Eijgelaar RS, de Witt Hamer PC, Barkhof F.
Estimating overall survival of glioblastoma patients using clinical variables, tumor size, and location.
Neurooncol Adv. 2025 Aug 3;7(1):vdaf154. doi: 10.1093/noajnl/vdaf154. PMID: 40842642. Observational study. ˍ

Patil N, Dube S, Mutua F, Kakumanu S, Shankar JJ, Sinha N, Pareek V.
Survival Impact of Isocitrate Dehydrogenase (IDH)-Wildtype Histological Versus Molecular Glioblastoma: A Propensity Score-Matched Analysis.
Cureus. 2025 Jul 24;17(7):e88667. doi: 10.7759/cureus.88667. PMID: 40861724. Observational study. ˍ

Rapp M, Fischer H, Steinmann J, Sabel M, Staub-Bartelt F.
Evaluation of Clinical Outcome and Survival Under Application of Various Therapies at First Recurrence in Patients with Glioblastoma.
J Clin Med. 2025 Sep 17;14(18):6550. doi: 10.3390/jcm14186550. PMID: 41010757. Observational study. ˍ

Parker A, Horsley P, Wheeler H, Venkatesha V, Kastelan M, Liu B, Back M.
Elderly Patients With Glioblastoma and Good Prognostic Factors May Achieve Equivalent Median Survival to Younger Patients When Managed With Standard Long-Course Rather Than Elderly Protocols.
J Med Imaging Radiat Oncol. 2025 Sep 19. doi: 10.1111/1754-9485.70020. PMID: 40971171. Observational study˰ ˍ

Shokr H, Liao WC, Faivre-Finn C, Dempsey C, Williams KJ, Chen LC.
Impact of statin use on survival and adverse events in patients with cancer receiving radiotherapy: a systematic review and meta-analysis.
BMC Cancer. 2025 Oct 29;25(1):1666. doi: 10.1186/s12885-025-15038-3. PMID: 41163198. Review; Meta-analysis. ˍ